Protagonist Therapeutics Set to Join S&P SmallCap 600

Seeking AlphaJun 28 15:26

Protagonist Therapeutics To Join S&P SmallCap 600, Effective Prior To Opening Of Trading On July 3

BenzingaJun 28 05:21

Encore Wire (NASDAQ:WIRE) Is Very Good At Capital Allocation

Yahoo FinanceJun 28 03:07

Are You Looking for a Top Momentum Pick? Why Encore Wire (WIRE) Is a Great Choice

Yahoo FinanceJun 22 00:00

Encore Wire, the Prysmian Buyout and Next Picks

Yahoo FinanceJun 7 22:00

Prysmian Obtains US Antitrust Clearance for Encore Wire Acquisition

MT NewswiresMay 29 16:16